At Interfector Therapeutics, our mission is to develop innovative biotechnology solutions that improve patients' quality of lives.
We aim to advance scientific research and enhance the quality of life for all individuals.
Explore our innovative biotechnology solutions aimed at improving patient lives. With over 50 years of combined expertise in medicine and drug discovery, we are dedicated to advancing scientific research and providing groundbreaking therapies for better health and longevity.
We have assembled a team of experts in medicine, pharmaceutical development, scientific research, and manufacturing, to understand and serve the needs of all patients. The team is growing, reach out to learn more.
Please reach us at info@interfectortherapeutics.com if you cannot find an answer to your question.
Created in 2024, Interfector Therapeutics is the product of a productive collaboration between the two co-founders: Daruka Mahadevan and Eloise Dray, and their teams. Driven by a common interest of addressing unmet needs in advanced cancers, they decided to unite their drug development pipeline and networks and create IT.
Stage four cancer, dementia, autoimmune diseases, all prevent a long and happy life.
We are committed to developing new efficient molecules that allow the prolongation of a high quality life.
We love to interact, so please email to schedule a visit during normal business hours.
Open today | 09:00 am – 05:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.